Cargando…
Organoid Model in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive- fibrosing disease characterized by extensive deposition of extracellular matrix (ECM), scarring of the lung parenchyma. Despite increased awareness of IPF, etiology and physiological mechanism of IPF are unclear. Therefore, preclinical m...
Autores principales: | Lee, Jooyeon, Kim, Jung-Hyun, Hong, Seok-Ho, Yang, Se-Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904526/ https://www.ncbi.nlm.nih.gov/pubmed/33122472 http://dx.doi.org/10.15283/ijsc20093 |
Ejemplares similares
-
Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing
por: Kim, Jung-Hyun, et al.
Publicado: (2021) -
Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice
por: Baek, Hyosin, et al.
Publicado: (2021) -
L-carnosine Attenuates Bleomycin-Induced Oxidative Stress via NFκB Pathway in the Pathogenesis of Pulmonary Fibrosis
por: Park, Jaehyun, et al.
Publicado: (2022) -
Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008) -
Clinical Predictors of Survival in Idiopathic Pulmonary Fibrosis
por: Kim, Ji Hye, et al.
Publicado: (2012)